» Articles » PMID: 1351500

Simultaneous Depletion of CD4+ and CD8+ T Lymphocytes is Required to Reactivate Chronic Infection with Toxoplasma Gondii

Overview
Journal J Immunol
Date 1992 Jul 1
PMID 1351500
Citations 257
Authors
Affiliations
Soon will be listed here.
Abstract

C57BL/6 mice chronically infected with an avirulent strain (ME-49) of Toxoplasma gondii were used to study the mechanisms by which T lymphocytes and IFN-gamma prevent reactivation of latent infection. Infected animals were treated with mAb, either anti-CD8, anti-CD4, anti-CD4 plus anti-CD8, anti-IFN-gamma, or anti-CD4 plus anti-IFN-gamma and the mice followed for survival, histopathology, cyst numbers, and spleen cell cytokine responses. In agreement with previously published findings, treatment with anti-IFN-gamma antibodies fully reactivated the asymptomatic infection, inducing massive necrotic areas in the brain with the appearance of free tachyzoites and death of all animals within 2 wk. Mice treated with the combination of anti-CD4 plus anti-CD8 antibodies showed augmented pathology and mortality nearly identical to the anti-IFN-gamma- treated animals. In contrast, treatment with anti-CD4 or anti-CD8 mAb alone failed to result in significantly enhanced brain pathology or mortality. In additional experiments, full reactivation of infection was observed in mice treated with anti-CD4 plus anti-IFN-gamma indicating that CD4+ lymphocytes are not required for the pathology resulting from IFN-gamma neutralization. Cytokine measurements on parasite Ag-stimulated spleen cells from mAb-treated mice indicated that both CD4+ and CD8+ cells produce IFN-gamma whereas only CD4+ cells contribute to parasite Ag-induced IL-2 synthesis. Together, these results suggest that CD4+ and CD8+ lymphocytes act additively or synergistically to prevent reactivation of chronic T. gondii infection probably through the production of IFN-gamma.

Citing Articles

Infection with Toxoplasma gondii triggers coagulation at the blood-brain barrier and a reduction in cerebral blood flow.

Hoover E, Schneider C, Crouzet C, Lima T, Velez D, Tran C J Neuroinflammation. 2025; 22(1):3.

PMID: 39780244 PMC: 11708167. DOI: 10.1186/s12974-024-03330-1.


Motility-dependent processes in tachyzoites and bradyzoites: same same but different.

Kent R, Ward G bioRxiv. 2024; .

PMID: 39386639 PMC: 11463423. DOI: 10.1101/2024.09.28.615543.


Toxoplasma gondii infection supports the infiltration of T cells into brain tumors.

Nguyen Y, Sibley L, Przanowski P, Zhao X, Kovacs M, Wang S J Neuroimmunol. 2024; 393:578402.

PMID: 38996717 PMC: 11318612. DOI: 10.1016/j.jneuroim.2024.578402.


The role of KLRG1: a novel biomarker and new therapeutic target.

Zhang Y, Chen S, Tang X, Peng Y, Jiang T, Zhang X Cell Commun Signal. 2024; 22(1):337.

PMID: 38898461 PMC: 11186184. DOI: 10.1186/s12964-024-01714-7.


IFNs in host defence and parasite immune evasion during infections.

Luder C Front Immunol. 2024; 15:1356216.

PMID: 38384452 PMC: 10879624. DOI: 10.3389/fimmu.2024.1356216.